AACR Stories
A decade after launching AACR Project GENIE, the international data-sharing initiative is powering advances in cancer precision medicine.
Learn More in AACR Stories
A decade after launching AACR Project GENIE, the international data-sharing initiative is powering advances in cancer precision medicine.
Learn More in AACR Stories
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of pediatric cancer.
Read the ReportMore than 42,000 adults in the United States are expected to be diagnosed with liver cancer in 2025. October is Liver Cancer Awareness Month. Read about the prevention, screening, and treatment options for this disease.
Learn MoreReducing Nicotine in Cigarettes: The Impact on Public Health
On the AACR BlogThe latest issue of Leading Discoveries magazine is online with articles on pioneering researchers, collaboration among blood cancer researchers, donors who are driving progress in cancer science, and more.
Read Leading DiscoveriesYour donation to the American Association for Cancer Research today will support AACR grant giving to fund promising projects by early-career investigators.
Donate NowEarly registration is now open. Register by Monday, January 5, to receive the lowest rates.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
